Access cutting-edge alzheimer's disease treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access alzheimer's disease specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alzheimer's disease treatment provided free
This is a Phase 3, 38-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with psychosis associated with Alzheimer's Disease. The primary objective of the study is to evaluate relapse prevention in subjects with psychosis associated with Alzheimer's Disease treated with KarXT compared to placebo. The secondary objectives of the study are to evaluate the time from randomization to discontinuation for any reason and safety and tolerability in subjects wit
Sponsor: Karuna Therapeutics
Check if you qualify for this alzheimer's disease clinical trial in Phoenix, AZ
If you're searching for alzheimer's disease treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alzheimer's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.